MedTrace Logo

Contact Sensitization Potential of 828 Ointment

NCT00767676 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 259

Last updated 2014-06-27

Study results available
· View outcomes & findings →

Summary

Contact sensitization by patch applications.

Conditions

  • Healthy Volunteers

Interventions

DEVICE

HP828-101

Nine topical patch applications over 3 weeks, rest period of 2 weeks and challenge after 48 hours.

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

  • Innes Cargill, PhD · Healthpoint

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767676 on ClinicalTrials.gov